PHILADELPHIA – A broad new strategy could hold hope for treating virtually all blood cancers with [CAR T cell therapy](https://www.pennmedicine.org/cancer/navigating-cancer-care/treatment-types/immunotherapy/what-is-car-t-therapy), which is currently approved for five subtypes of blood cancer. Scientists in the Perelman School of Medicine at the University of Pennsylvania have demonstrated the potential efficacy of this approach in preclinical tests. In the
Read More
